Page last updated: 2024-11-04

propantheline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Propantheline bromide is an anticholinergic drug that blocks the action of acetylcholine at muscarinic receptors in the body. It is used to treat a variety of conditions, including irritable bowel syndrome, peptic ulcer disease, and urinary incontinence. Propantheline is typically taken orally, and it can cause side effects such as dry mouth, blurred vision, and constipation. The mechanism of action involves competitively inhibiting the binding of acetylcholine to muscarinic receptors, thereby reducing the effects of the parasympathetic nervous system. This drug is studied for its potential to improve the quality of life in patients with gastrointestinal and urinary disorders. Its synthesis involves several chemical steps, starting with the reaction of 2-diethylaminoethyl chloride with propionic acid.'

Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID4934
CHEMBL ID1180725
CHEBI ID8481
SCHEMBL ID80089
MeSH IDM0017746

Synonyms (75)

Synonym
gtpl329
DIVK1C_000802
KBIO1_000802
SPECTRUM_000870
BSPBIO_000753
lopac-p-8891
NCGC00016219-01
NCGC00015854-01
cas-50-34-0
IDI1_000802
LOPAC0_001014
PRESTWICK3_000827
PRESTWICK2_000827
BSPBIO_002436
BPBIO1_000829
AB00053808
C07506 ,
298-50-0
propantheline
DB00782
propanthelinium
ammonium, (2-hydroxyethyl)diisopropylmethyl-, xanthene-9-carboxylate (ester)
2-propanaminium, n-methyl-n-(1-methylethyl)-n-(2-((9h-xanthen-9-ylcarbonyl)oxy)ethyl)-
propanthelinum
hsdb 3174
einecs 206-063-2
KBIO2_003918
KBIO2_001350
KBIO2_006486
KBIO3_001764
KBIOSS_001350
KBIOGR_001345
SPBIO_001339
NINDS_000802
SPECTRUM2_001300
PRESTWICK0_000827
SPBIO_002674
PRESTWICK1_000827
SPECTRUM3_000882
SPECTRUM4_000973
SPECTRUM5_001076
NCGC00015854-02
NCGC00021543-03
NCGC00015854-07
L001263
methyl-di(propan-2-yl)-[2-(9h-xanthene-9-carbonyloxy)ethyl]azanium
chebi:8481 ,
propantheline cation
CHEMBL1180725
propantheline ion
CCG-205094
NCGC00015854-03
NCGC00015854-05
NCGC00015854-06
NCGC00015854-04
1306v2b0q8 ,
unii-1306v2b0q8
FT-0603371
propantheline [vandf]
2-propanaminium, n-methyl-n-(1-methylethyl)-n-(2-((9h-xanthen-9- ylcarbonyl)oxy)ethyl)
propantheline [hsdb]
propantheline [who-dd]
SCHEMBL80089
DTXSID6047230
propanthelin
AB00053808_15
methylbis(propan-2-yl){2-[(9h-xanthen-9-yl)carbonyloxy]ethyl}azanium
[2-[(9h-xanthen-9-ylcarbonyl)oxy]ethyl]diisopropylmethylaminium
SBI-0050987.P003
Q3275451
VVWYOYDLCMFIEM-UHFFFAOYSA-N
NCGC00015854-14
HY-B1188A
CS-0013759
2-propanaminium, n-methyl-n-(1-methylethyl)-n-(2-((9h-xanthen-9-ylcarbonyl)oxy)ethyl)

Research Excerpts

Overview

Propantheline bromide (PB) is a hydrolysable anti-cholinergic drug. It causes xerostomia by decreasing salivation.

ExcerptReferenceRelevance
"Propantheline bromide (PB) is a hydrolysable anti-cholinergic drug. "( Novel strategy for online monitoring of the degradation kinetics of propantheline bromide via a calixarene-based ion-selective electrode.
Abd El-Rahman, MK; Badr ElDin, N; Moustafa, AA; Zaazaa, HE, 2015
)
2.1
"Propantheline is an anticholinergic that causes xerostomia by decreasing salivation."( Propantheline prevention of mucositis from etoposide.
Ahmed, T; Chun, H; Cook, P; Coombe, N; Corbi, D; Engelking, C; Helson, L; Mittelman, A; Puccio, C; Szalyga, J, 1993
)
2.45
"Propantheline bromide is a synthetic quaternary ammonium compound widely used in urologic patients to block the action of acetylcholine at the postganglionic nerve endings of the bladder's parasympathetic innervation. "( Propantheline as a diagnostic tool--a serious complication.
Fuchs, E; Kay, R; Poole, R, 1977
)
3.14

Treatment

Treatment with propantheline on average delayed the maximal plasma level of hct from 2.4 to 4.8 h. The total urinary recovery of hydrochlorothiazide by 48 h was increased from 49.3 mg to 66.9 mg (p less than 0.005)

ExcerptReferenceRelevance
"The propantheline-treatment reduced the transit rate in all segments to approximately 50%."( Absorption behavior of orally administered drugs in rats treated with propantheline.
Haruta, S; Higaki, K; Iwasaki, N; Kimura, T; Ogawara, K, 1998
)
1.01
"Pretreatment with propantheline on average delayed the maximal plasma level of hct from 2.4 to 4.8 h (p less than 0.05); and the total urinary recovery of hydrochlorothiazide by 48 h was increased from 49.3 mg to 66.9 mg (p less than 0.005)."( Enhancement of the gastrointestinal absorption of hydrochlorothiazide by propantheline.
Beermann, B; Groschinsky-Grind, M, 1978
)
0.81
"Treatment with propantheline or metoclopramide was given 30 min before dosing with the antibiotic and the radioisotope."( Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil.
Batts, DH; Euler, AR; Heald, DL; Hughes, GS; Patel, R; Spillers, CR, 1990
)
0.62
"Treatment with propantheline, in a dose sufficient to reduce the amplitude of sinus arrhythmia to normal, abolished her symptoms."( A case of respiratory sinus arrhythmia and vasovagal attacks: use of cosinor analysis for diagnosis and for monitoring treatment.
Pai, GR; Rawles, JM, 1987
)
0.61

Toxicity

ExcerptReferenceRelevance
" Fourteen compounds without previously known ototoxicity were discovered to be selectively toxic to hair cells."( Using the zebrafish lateral line to screen for ototoxicity.
Chiu, LL; Cunningham, LL; Ou, HC; Raible, DW; Rubel, EW, 2008
)
0.35

Pharmacokinetics

Pharmacokinetic profiling of an orally administered MEL salt was also carried out in both normal rats and rats treated with propantheline for the suppression of gastric motility. The means and variances of the pharmacokinetic parameters of the cis and trans isomers of cefprozil were similar in fasting subjects and were affected in a parallel manner by food, metoclopramide, propant heline and probenecid.

ExcerptReferenceRelevance
"The indications, contraindications and usefulness of pharmacodynamic tests in current radiological diagnosis of diseases of the digestive tract are reviewed and iscussed."( [The employment of pharmacodynamic tests in the radiological examination of the digestive tract (author's transl)].
Basilico, L; Bonomo, L; Lupini, A; Renda, F, 1978
)
0.26
" The means and variances of the pharmacokinetic parameters of the cis and trans isomers of cefprozil were similar in fasting subjects and were affected in a parallel manner by food, metoclopramide, propantheline, and probenecid."( Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.
Barbhaiya, RH; Pittman, KA; Shukla, UA, 1992
)
0.72
" The mean peak plasma concentration, mean area under plasma concentration time curve and mean half-life of cefpodoxime proxetil were similar in all groups as compared to control."( Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil.
Batts, DH; Euler, AR; Heald, DL; Hughes, GS; Patel, R; Spillers, CR, 1990
)
0.28
" The aim of the present study was to investigate the effect of delayed gastric emptying and intestinal transit on pharmacokinetic parameters of lithium."( The effect of delayed gastric emptying and absorption on pharmacokinetic parameters of lithium.
Bellibaş, SE; Kayali, A; Tuğlular, I,
)
0.13
" Serial (0-48h) blood samples were collected for pharmacokinetic and bioavailability studies."( Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
Aghazadeh-Habashi, A; Jamali, F, 2008
)
0.35
" Pharmacokinetic profiling of an orally administered MEL salt was also carried out in both normal rats and rats treated with propantheline for the suppression of gastric motility."( Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.
Inoue, R; Ochi, M; Onoue, S; Yamada, S; Yamauchi, Y, 2013
)
0.6
" The pharmacokinetic effect of morphine on plasma etoposide concentration after the oral concomitant use of etoposide and morphine in rats was assessed using a population analysis approach."( Pharmacokinetic assessment of absorptive interaction of oral etoposide and morphine in rats.
Iwanaga, K; Kakemi, M; Minamida, M; Miyazaki, M; Nishimura, C, 2014
)
0.4

Compound-Compound Interactions

ExcerptReferenceRelevance
"Forty-three children with overt neurological disease and neuropathic vesicourethral dysfunction were entered into a trial comparing clean intermittent catheterisation (CIC) with manual expression combined with drug treatment (non-CIC)."( Neuropathic vesicourethral dysfunction in children. A trial comparing clean intermittent catheterisation with manual expression combined with drug treatment.
Borzyskowski, M; Chantler, C; Haycock, GB; Joyce, MR; Kinder, CH; Mundy, AR; Neville, BG; Park, L, 1982
)
0.26
"Only drug-drug interactions that are believed clinically important and that are primarily pharmacokinetic in nature are discussed in this article."( Therapeutic implications of drug interactions with acetaminophen and aspirin.
Hayes, AH, 1981
)
0.26

Bioavailability

Propantheline bromide increased the relative bioavailability of ranitidine by 22%. The antacid had no significant effect on runningitidine absorption. Six normal men received three standard Pro-Banthine 15 mg tablets.

ExcerptReferenceRelevance
" These results indicate that absorption rate of droxicam has been modified but bioavailability does not suffer modification in conditions of altered gastric emptying."( The influence of gastric emptying on droxicam pharmacokinetics.
Bartlett, A; García-Barbal, J; Martínez, L; Roser, R; Sagarra, R; Sánchez, J, 1989
)
0.28
"The absolute and relative bioavailability of nizatidine, an H2-blocker, was studied in healthy male volunteers."( Absorption studies of the H2-blocker nizatidine.
Bergstrom, RF; Callaghan, JT; Knadler, MP; Obermeyer, BD; Rubin, A, 1987
)
0.27
" Bioavailability is enhanced by food or propantheline."( Nitrofurantoin.
D'Arcy, PF,
)
0.4
" Taken as a whole, these data suggest that the effect of meals to increase bioavailability of CGZ could be mediated at least in part, through an increase in GI residence time."( Bioavailability studies with ciglitazone in beagles. II. Effect of propantheline bromide and metoclopramide HCL on bioavailability of a tablet.
Capponi, VJ; Cox, SR; Harrington, EL,
)
0.37
" Bioavailability was determined from steady-state, 24-hour area under the serum concentration-time curve (AUC, ng X h/mL) and from 0- and 24-hour trough serum digoxin concentrations (ng/mL)."( A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
Brown, DD; Hull, JH; Long, RA; Schmid, J,
)
0.39
" Other similar absorption interactions probably occur since drugs are poorly absorbed from the stomach and many therapeutic agents influence gastrointestinal motility."( Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption.
Heading, RC; Nimmo, J; Prescott, LF; Tothill, P, 1973
)
0.49
" These mechanisms include: (1) impaired hepatic drug metabolism due to inhibition of hepatic microsomal enzymes, (2) reduced hepatic blood flow, resulting in decreased clearance of drugs that are highly extracted by the liver, (3) increased potential for myelosuppression when administered concurrently with other drugs capable of causing myelosuppression, and (4) altered bioavailability of acid-labile drugs."( Review of cimetidine drug interactions.
Darvey, DL; Sorkin, EM, 1983
)
0.27
" The antacid had no significant effect on ranitidine absorption, but propantheline increased the relative bioavailability of ranitidine by 22%."( The effects of antacid and propantheline on the absorption of oral ranitidine.
Donn, KH; Eshelman, FN; Fabre, L; Plachetka, JR; Powell, JR,
)
0.66
"The bioavailability of metoprolol was studied in eight healthy young and seven healthy elderly volunteers."( Bioavailability of metoprolol in young adults and the elderly, with additional studies on the effects of metoclopramide and probanthine.
Briant, RH; Dorrington, RE; Ferry, DG; Paxton, JW, 1983
)
0.27
"To determine the comparative bioavailability of three oral formulations of propantheline bromide (PB) by both pharmacokinetic and pharmacodynamic parameters, six normal men received three standard Pro-Banthine 15 mg tablets, two prolonged acting (PA) Pro-Banthine 30 mg tablets or one developmental PA Pro-Banthine 45 mg capsule, in a study of balanced random crossover design."( Propantheline bromide plasma level, urinary excretion and pharmacological data in a comparison of the bioavailability of three oral formulations of Pro-Banthine.
Allan, EF; Brownsill, RD; Ford, GC; Harrison, IR; Haskins, NJ; Hawkins, AJ; Perkins, RM; Rigby, GV; Shelton, JR; Vose, CW,
)
1.8
" It is concluded that the negative effect of the antacid on the bioavailability of atenolol is caused by a reduction in the in vivo dissolution rate due to increased gastric pH."( The effect of antacid, metoclopramide, and propantheline on the bioavailability of metoprolol and atenolol.
Lundborg, P; Persson, BA; Regårdh, CG,
)
0.39
" However, the extent of bioavailability was not changed in theophylline and cephalexin."( Absorption behavior of orally administered drugs in rats treated with propantheline.
Haruta, S; Higaki, K; Iwasaki, N; Kimura, T; Ogawara, K, 1998
)
0.53
" We studied the pharmacokinetics of meloxicam and the effect of vagal suppression on the oral bioavailability and bioequivalence using a marketed (Brand) and a fast dissolving (FD) formulation."( Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
Aghazadeh-Habashi, A; Jamali, F, 2008
)
0.35
" That is, morphine and quinidine significantly increased the bioavailability of etoposide believed to be due to competitive P-gp inhibition in the intestine."( Pharmacokinetic assessment of absorptive interaction of oral etoposide and morphine in rats.
Iwanaga, K; Kakemi, M; Minamida, M; Miyazaki, M; Nishimura, C, 2014
)
0.4
" Pharmacokinetic experiments show oral bioavailability through gastric absorption."( Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
Cescon, DW; Hansen, MD; Hoj, JP; Siddiqui-Jain, A, 2018
)
0.48

Dosage Studied

A pharmacokinetic study on orally dosed CEL samples (5-mg CEL/kg) was carried out in normal and propantheline (PPT)-treated rats to mimic impaired gastric motility. It is suggested that there is need for greater awareness of the marked reduction in bioavailablity that results when the drug is administered at conventional therapeutic dosage.

ExcerptRelevanceReference
" Prolonged-release dosage forms of these drugs produced effects comparable to those produced by much smaller doses in conventional tablets and gave no indication of providing prolonged anticholinergic effects."( Biopharmaceutic factors that influence effects of anticholinergic drugs: comparison of propantheline, hexocyclium, and isopropamide.
Gibaldi, M; Grundhofer, B, 1977
)
0.48
" Drug dosage and time after the drug effect was measured varied."( [Comparative study on the effect of anticholinergic substances on basic gastric secretion as well as on gastric secretion stimulated by pentagastrin or hypoglycemia (author's transl)].
Brenner, U; Kutz, K; Miederer, SE; Schuler, G, 1976
)
0.26
" It is suggested that when propantheline is selected as an anticholinergic for clinical use, there is need for greater awareness of the marked reduction in bioavailablity that results when the drug is administered at conventional therapeutic dosage by the oral as opposed to the intravenous route."( Effects of intravenous and oral propantheline and metoclopramide on ethanol absorption.
Gibbons, DO; Lant, AF, 1975
)
0.83
" The three diarrheal agents, administered intraperitoneally, showed dose-dependent and parallel dose-response curves with the following order of decreasing potency: PGF2 alpha, methacholine and 5-HTP."( Naloxone reversal of drug-induced diarrhea in mice.
Bertermann, RE; Dajani, EZ; Roge, EA; Schweingruber, FL; Woods, EM, 1979
)
0.26
"A method is described for the isolation and identification of propantheline bromide from bulk drug substances and dosage forms, both alone and in combination with other drug substances."( Identification tests for propantheline bromide.
Benson, WR; Brannon, WL; Smith, MM, 1979
)
0.8
" Intragastric administration of PB, CM or TP produced dose-dependent inhibition of gastric ulceration with parallel dose-response curves."( Synergistic actions of propantheline bromide with cimetidine and thiopropazate hydrochloride in the prevention of stress ulcer formation in rats.
Bianchi, RG; Calhoun, DW; Dajani, EZ, 1979
)
0.57
"A gastroduodenal combination preparation was introduced at a deliberately high dosage into a clinical treatment schema."( [Clinical treatment of inflammatory and benign ulcerous diseases of the stomach and duodenum with a new combination preparation (Aci-Tensilan) (author's transl)].
van de Loo, W, 1976
)
0.26
" In 1 subject, a dose-response relationship was noted after 15 mg and 30 mg doses under both fasting and fed conditions, but at each dose level the influence of food was clear."( Biopharmaceutic influences on the anticholinergic effects of propantheline.
Gibaldi, M; Grundhofer, B, 1975
)
0.5
" All patients received propantheline orally at a dosage of 15 mg/6 hours."( [Treatment with propantheline for urinary incontinence caused by bladder instability in the elderly].
Cruz Jentoft, AJ; de Antonio García, MP; Ribera Casado, JM; Salinas Casado, J; Verdejo Bravo, C, 1992
)
0.94
" Baseline pH measurements were recorded for 60 min prior to dosing with 10 g of lactulose in three of the periods."( New methods to detect the effect of alteration in gastric pH and intestinal transit by metoclopramide and propantheline using a continuous gastric pH probe and hydrogen breath analysis.
Bays, M; Bohan, DF; Francom, SF; Hughes, GS; VanderLugt, JT, 1990
)
0.49
" Treatment with propantheline or metoclopramide was given 30 min before dosing with the antibiotic and the radioisotope."( Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil.
Batts, DH; Euler, AR; Heald, DL; Hughes, GS; Patel, R; Spillers, CR, 1990
)
0.63
" A 10 mg dose of MCP was given 15 min prior to dosing with CGZ and repeated 1 h after dosing."( Bioavailability studies with ciglitazone in beagles. II. Effect of propantheline bromide and metoclopramide HCL on bioavailability of a tablet.
Capponi, VJ; Cox, SR; Harrington, EL,
)
0.37
" This study evaluated whether digoxin solution in capsules, a new dosage form with 90% to 100% bioavailability, would reduce such alterations, specifically those caused by cholestyramine and propantheline bromide."( A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
Brown, DD; Hull, JH; Long, RA; Schmid, J,
)
0.58
" This diabetes insipidus is reversible, non-progressive, unrelated to plasma level, and distinct in attack from lithium-induced hypothyroidism, which may occur at low dosage but is also usually of late onset and reversible or treatable with thyroxine while lithium is continued."( Blood levels and management of lithium treatment.
Crammer, JL; Crane, G; Rosser, RM, 1974
)
0.25
" In concentrations blocking the brain H2-receptors, these derivatives had no effect on atrial histamine dose-response curves, but evidence for their antagonism on peripheral H2-receptors was obtained with papillary muscle preparations."( Histamine H2-receptor antagonism by propantheline and derivatives.
Barker, LA; Hough, LB, 1981
)
0.54
" At doses of 10(-6)-3 x 10(-5) M, propiverine caused both a rightward shift and inhibition of the maximum response in the acetylcholine (ACh) dose-response curve."( [Effects of propiverine hydrochloride (propiverine) on isolated rat and dog urinary bladder].
Kaneko, S; Nakano, D; Nishimori, T; Ohara, M, 1999
)
0.3
" Flow-through electrodes, selective to chlorpromazine, amitriptyline, propantheline, cimetidine, and ranitidine, have been constructed and used for the dissolution studies of 18 dosage forms using the rotating basket apparatus."( Dissolution studies of drug formulations using ion-selective electrodes as sensors in an air-segmented continuous flow analyzer.
Christopoulos, TK; Diamandis, EP; Koupparis, MA; Mitsana-Papazoglou, A, 1987
)
0.51
" These findings have significant implications in the design of a metformin modified release dosage form."( Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.
Barbhaiya, RH; Greene, DS; Marathe, PH; Norton, J; Wen, Y; Wilding, IR, 2000
)
0.31
" Dose-response curves for all 21 ototoxic compounds were determined by quantifying hair cell survival as a function of drug concentration."( Using the zebrafish lateral line to screen for ototoxicity.
Chiu, LL; Cunningham, LL; Ou, HC; Raible, DW; Rubel, EW, 2008
)
0.35
"It is believed that acute pain suppresses nervus vagus, thereby, influencing gastrointestinal secretion and motility, which are the two factors that are necessary for disintegration and dissolution of solid dosage forms."( Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
Aghazadeh-Habashi, A; Jamali, F, 2008
)
0.35
" 18-fold reduction of AUC(0-4) for orally dosed crystalline MEL (1."( Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.
Inoue, R; Ochi, M; Onoue, S; Yamada, S; Yamauchi, Y, 2013
)
0.39
"Compounds were dosed in conscious rats and mice."( Pharmacological comparison of peristaltic effects in rats and mice.
Larson, KJ; Martin, RL; Polakowski, JS; Shaughnessy, TK,
)
0.13
" These candidates were subjected to a dose-response bioactivity assay, measuring an increase in α-tubulin K40 acetylation in two neuronal cell lines, which yielded five compounds bioactive in both cell lines and eight compounds bioactive in at least one of the cell lines tested."( Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.
Choi, SH; Kazantsev, AG; Khanfar, MA; Quinti, L; Silverman, RB; Wang, H, 2014
)
0.4
" A pharmacokinetic study on orally dosed CEL samples (5-mg CEL/kg) was carried out in normal and propantheline (PPT)-treated rats to mimic impaired gastric motility."( Self-Emulsifying Drug Delivery System of Celecoxib for Avoiding Delayed Oral Absorption in Rats with Impaired Gastric Motility.
Ogino, M; Onoue, S; Sato, H; Seto, Y; Suzuki, H; Yakushiji, K, 2020
)
0.78
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
xanthenes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATAD5 protein, partialHomo sapiens (human)Potency23.09990.004110.890331.5287AID493107
NFKB1 protein, partialHomo sapiens (human)Potency11.22020.02827.055915.8489AID895; AID928
thyroid stimulating hormone receptorHomo sapiens (human)Potency7.94330.001318.074339.8107AID926; AID938
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency4.74440.035520.977089.1251AID504332
cytochrome P450 2D6 isoform 1Homo sapiens (human)Potency16.44090.00207.533739.8107AID891
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency15.84890.031610.279239.8107AID884; AID885
muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Potency0.00610.00106.000935.4813AID943; AID944
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (75)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1472421Half life in human plasma at 1 uM by HPLC-MS/MS analysis2018Journal of medicinal chemistry, 01-11, Volume: 61, Issue:1
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.
AID1390728Metabolic stability in human plasma assessed as parent compound remaining at 100 uM after 120 mins by LC-MS/MS analysis2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain.
AID1374468Stability in human plasma assessed as parent compound remaining after 8 hrs relative to initial time2018Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5
Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1891106Metabolic stability in human plasma assessed as parent compound remaining at 200 uM measured after 60 min by LC-MS/MS analysis relative to control2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1891104Metabolic stability in human plasma assessed as parent compound remaining at 200 uM measured after 15 min by LC-MS/MS analysis relative to control2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1891107Metabolic stability in human plasma assessed as parent compound remaining at 200 uM measured after 90 min by LC-MS/MS analysis relative to control2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID679788TP_TRANSPORTER: serosal to mucosal transport in SD rat intestinal segment1995Pharmaceutical research, Sep, Volume: 12, Issue:9
Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.
AID1891108Metabolic stability in human plasma assessed as parent compound remaining at 200 uM measured after 120 min by LC-MS/MS analysis relative to control2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1129452Metabolic stability in mouse plasma assessed as compound remaining at 5 uM2014European journal of medicinal chemistry, Apr-09, Volume: 76Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1390717Metabolic stability in human plasma assessed as parent compound remaining at 100 uM after 30 mins by LC-MS/MS analysis2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain.
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1667358Microsomal stability in human liver microsomes assessed as parent compound remaining measured after 60 mins2020Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8
Identification of C10 nitrogen-containing aporphines with dopamine D
AID1665949Stability in mouse liver S9 fraction assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID1390722Metabolic stability in human plasma assessed as parent compound remaining at 100 uM after 10 mins by LC-MS/MS analysis2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain.
AID1667357Microsomal stability in human liver microsomes assessed as parent compound remaining measured after 30 mins2020Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8
Identification of C10 nitrogen-containing aporphines with dopamine D
AID1374465Stability in human plasma assessed as parent compound remaining after 75 mins relative to initial time2018Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5
Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID592683Apparent permeability from basolateral side to apical side of human Caco2 cells by LC/MS/MS analysis2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
QSAR-based permeability model for drug-like compounds.
AID1667356Microsomal stability in human liver microsomes assessed as parent compound remaining measured after 15 mins2020Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8
Identification of C10 nitrogen-containing aporphines with dopamine D
AID1665947Stability in rat liver S9 fraction assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID1665948Stability in mouse plasma assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID1665944Stability in human plasma assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID1891109Metabolic stability in human plasma assessed as half life at 200 uM by LC-MS/MS analysis relative to control2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.
AID1665946Stability in rat plasma assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID1874533Stability in mouse plasma assessed as parent compound remaining at 1 uM measured after 2 hrs by LC-MS/MS analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits.
AID615024Half life in human plasma2009Bioorganic & medicinal chemistry, May-15, Volume: 17, Issue:10
QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design.
AID1667355Microsomal stability in human liver microsomes assessed as parent compound remaining measured immediately2020Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8
Identification of C10 nitrogen-containing aporphines with dopamine D
AID1874532Stability in human plasma assessed as parent compound remaining at 1 uM measured after 2 hrs by LC-MS/MS analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits.
AID1374466Stability in human plasma assessed as parent compound remaining after 2 hrs relative to initial time2018Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5
Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
AID1129451Half life in mouse plasma at 5 uM2014European journal of medicinal chemistry, Apr-09, Volume: 76Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1390727Metabolic stability in human plasma assessed as parent compound remaining at 100 uM after 60 mins by LC-MS/MS analysis2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain.
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1374469Stability in human plasma assessed as parent compound remaining after 24 hrs relative to initial time2018Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5
Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
AID1397460Metabolic stability in human plasma assessed as compound remaining measured after 120 mins2018Bioorganic & medicinal chemistry letters, 09-15, Volume: 28, Issue:17
Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors.
AID1374467Stability in human plasma assessed as parent compound remaining after 4 hrs relative to initial time2018Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5
Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
AID1667359Microsomal stability in human liver microsomes assessed as parent compound remaining measured after 120 mins2020Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8
Identification of C10 nitrogen-containing aporphines with dopamine D
AID1665945Stability in human liver S9 fraction assessed as parent compound remaining at 1 uM measured after 4 hrs by LC-MS/MS analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses.
AID592682Apparent permeability from apical to basolateral side of human Caco2 cells after 2 hrs by LC/MS/MS analysis2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
QSAR-based permeability model for drug-like compounds.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1345286Human M1 receptor (Acetylcholine receptors (muscarinic))2001AAPS pharmSci, , Volume: 3, Issue:4
Receptor binding studies of soft anticholinergic agents.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))2001AAPS pharmSci, , Volume: 3, Issue:4
Receptor binding studies of soft anticholinergic agents.
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))2001AAPS pharmSci, , Volume: 3, Issue:4
Receptor binding studies of soft anticholinergic agents.
AID1345343Human M3 receptor (Acetylcholine receptors (muscarinic))2001AAPS pharmSci, , Volume: 3, Issue:4
Receptor binding studies of soft anticholinergic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (561)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990471 (83.96)18.7374
1990's41 (7.31)18.2507
2000's19 (3.39)29.6817
2010's19 (3.39)24.3611
2020's11 (1.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.37 (24.57)
Research Supply Index6.54 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index118.27 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (67.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials94 (15.72%)5.53%
Reviews19 (3.18%)6.00%
Case Studies43 (7.19%)4.05%
Observational0 (0.00%)0.25%
Other442 (73.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
the Therapeutic Effect Treated With Tamsulosin After ESWL in Urinary Calculus [NCT01010048]Phase 4120 participants (Anticipated)Interventional2009-10-31Recruiting
A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder [NCT01640002]Phase 142 participants (Anticipated)Interventional2012-05-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]